The Connection Between ABA Compliance and Exits with Brandon Zarsky

The Connection Between ABA Compliance and Exits with Brandon Zarsky

ABA Compliance & Legal Series

How Compliance Shapes ABA Transactions: Buyers, Diligence, and Deal Terms

Host: Tzvi Weiser (NUCO Filings)
Guest: Brandon Zarsky (Partner, Frier Levitt)
Episode: 04
Date: February __, 2026
Category: ABA transactions, compliance, diligence, MSO/CPOM, private equity

Building or expanding an ABA company across states and want clean entity formation, registered agent coverage, and ongoing compliance tracking?
Contact NUCO Filings or learn how we work.


Episode summary

Most ABA owners treat “compliance” like a defensive function, something you deal with when an audit shows up. In reality, buyers treat compliance as a valuation input.

It determines who shows up, how fast the deal moves, whether you get a platform multiple or a bolt-on multiple, and how much risk you carry after closing through escrows, indemnities, deferred payments, and rollover equity.

Brandon Zarsky breaks down how different buyer types underwrite risk, where diligence teams focus first, and which issues are fixable late versus the ones you cannot “clean up” once you go to market.

Key takeaways

  • Buyer type matters: platform vs bolt-on; private equity vs strategic; each weights risk differently.
  • Governance is diligence #1: operating agreement / shareholder rules, vote thresholds, drag/tag, and “rogue owner” problems can delay or derail deals.
  • Risk drives multiple: audit history, prepayment review, investigations, billing/coding, and structure directly influence valuation and deal terms.
  • Deal structure shifts liability: asset vs equity, MSO models, whether the clinical entity continues, and how recoupments can flow into escrows and deferred consideration.
  • Sell-side prep wins: internal coding audits, quality of earnings, clean contracts/assignability, active licenses, and remediated issues move you into “mature/scalable” territory.

Topics we cover

  • Who sits at the buyer’s table in ABA (strategics, PE, add-on buyers) and what each wants
  • Platform vs bolt-on: what changes in diligence intensity and pricing
  • How compliance issues translate into deal mechanics (escrow, indemnity, deferred payments, rollover equity)
  • Regulatory scrutiny trends impacting healthcare PE and MSO structures
  • 8 diligence buckets: org docs, assets/encumbrances, billing/coding, investigations, contracts, licenses, tax/finance, operational discipline
  • What you must fix 3–5 years pre-exit vs what you can remediate quickly

Who this episode is for

  • ABA owners thinking about a sale in the next 1–5 years
  • Operators building toward multi-site or multi-state expansion
  • Clinician-owners who want to understand MSO/CPOM implications
  • Anyone who wants a practical diligence map (not theory)

Disclaimer: This podcast is for informational purposes only and does not constitute legal advice. For advice on your specific facts, consult qualified counsel.

© NUCO Filings LLC


Support
whenever you
need it